Cargando…

Re: “Immunothrombotic dysregulation in chagas disease and COVID‑19: a comparative study of anticoagulation”

Detalles Bibliográficos
Autor principal:	Hasslocher-Moreno, Alejandro Marcel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771619/ https://www.ncbi.nlm.nih.gov/pubmed/35050454 http://dx.doi.org/10.1007/s11010-022-04361-z

Ejemplares similares

Re. Re.: “Immunothrombotic dysregulation in Chagas disease and COVID19: a comparative study of anticoagulation”
por: Pérez-Campos Mayoral, Laura, et al.
Publicado: (2022)

Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation
por: Pérez-Campos Mayoral, Laura, et al.
Publicado: (2021)

Re: “Challenges of addressing neglected tropical diseases amidst the COVID-19 pandemic in Africa: A case of Chagas Disease”
por: Hasslocher-Moreno, Alejandro Marcel
Publicado: (2022)

Vitronectin promotes immunothrombotic dysregulation in the venular microvasculature
por: Uhl, Bernd, et al.
Publicado: (2023)

Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy
por: Nicolai, Leo, et al.
Publicado: (2020)

Severe COVID-19 as a virus-independent immunothrombotic process
por: Cherian, Robin, et al.
Publicado: (2022)

Letters to the Editor: Indeterminate form of Chagas Disease: some immunological insights
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2022)

Indeterminate form of Chagas disease: historical, conceptual, clinical, and prognostic aspects
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2021)

Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2022)

Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone
por: Keskinidou, Chrysi, et al.
Publicado: (2021)

Impact of COVID-19 In-hospital Mortality in Chagas Disease Patients
por: Sperandio da Silva, Gilberto Marcelo, et al.
Publicado: (2022)

Myocardial Edema without Fibrosis by Magnetic Resonance T2 Mapping in Acute Chagas’ Myocarditis
por: de Sousa, Andréa Silvestre, et al.
Publicado: (2017)

Ageing with Chagas disease: an overview of an urban Brazilian cohort in Rio de Janeiro
por: Vizzoni, Alexandre Gomes, et al.
Publicado: (2018)

VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study
por: Madeeva, Daria V, et al.
Publicado: (2020)

Corrigendum: Impact of COVID-19 in-hospital mortality in chagas disease patients
por: Sperandio da Silva, Gilberto Marcelo, et al.
Publicado: (2022)

ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis
por: Brasil, Pedro EAA, et al.
Publicado: (2010)

Discussing the Score of Cardioembolic Ischemic Stroke in Chagas Disease
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2020)

Two-dimensional strain derived parameters provide independent predictors of progression to Chagas cardiomyopathy and mortality in patients with Chagas disease
por: Saraiva, Roberto M., et al.
Publicado: (2022)

The Search for Biomarkers and Treatments in Chagas Disease: Insights From TGF-Beta Studies and Immunogenetics
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: Correlation between antibody titers and development of cardiac disease severity
por: Georg, Ingebourg, et al.
Publicado: (2017)

Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: de Buhr, Nicole, et al.
Publicado: (2022)

Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital Warts
por: Braun, Stephan A., et al.
Publicado: (2022)

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023)

Chagas disease mortality during the coronavirus disease 2019 pandemic: A Brazilian referral center experience
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2022)

Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil
por: Rodrigues-dos-Santos, Ícaro, et al.
Publicado: (2018)

Sustained and intermittent hypoxia differentially modulate primary monocyte immunothrombotic responses to IL-1β stimulation
por: Wahlund, Casper J.E., et al.
Publicado: (2023)

Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care
por: Saraiva, Roberto M, et al.
Publicado: (2021)

Adverse drug events and the associated factors in patients with chronic Chagas disease
por: Lopes, Luiza Braz da Cunha, et al.
Publicado: (2020)

Molecular Basis for Paradoxical Activities of Polymorphonuclear Neutrophils in Inflammation/Anti-Inflammation, Bactericide/Autoimmunity, Pro-Cancer/Anticancer, and Antiviral Infection/SARS-CoV-II-Induced Immunothrombotic Dysregulation
por: Wu, Tsai-Hung, et al.
Publicado: (2022)

FIRST REPORT OF ACUTE CHAGAS DISEASE BY VECTOR TRANSMISSION IN RIO DE JANEIRO STATE, BRAZIL
por: SANGENIS, Luiz Henrique Conde, et al.
Publicado: (2015)

Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial
por: da Silva, Gilberto M Sperandio, et al.
Publicado: (2012)

Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults
por: Eppensteiner, John, et al.
Publicado: (2018)

The association of exercise test variables with long-term mortality in patients with chronic Chagas disease
por: Silva, Rudson S., et al.
Publicado: (2022)

Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): A study protocol for a randomized clinical trial
por: Mediano, Mauro F. F., et al.
Publicado: (2023)

Association between Trypanosoma cruzi DTU TcII and chronic Chagas disease clinical presentation and outcome in an urban cohort in Brazil
por: Nielebock, Marco Antonio Prates, et al.
Publicado: (2020)

Biomarkers and Echocardiographic Predictors of Cardiovascular Outcome in Patients With Chronic Chagas Disease
por: Mendes, Veronica G., et al.
Publicado: (2023)

Spatial Re-Establishment Dynamics of Local Populations of Vectors of Chagas Disease
por: zu Dohna, Heinrich, et al.
Publicado: (2009)

Corrigendum: Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): a study protocol for a randomized clinical trial
por: Mediano, Mauro F. F., et al.
Publicado: (2023)

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
por: Silva, Paula Simplício da, et al.
Publicado: (2017)

COVID-19: Implications for People with Chagas Disease
por: Zaidel, Ezequiel José, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_74b726fr4hg0fhib6brstapbrn